Page 2 - Cures Act News Today

Experts explore using technology and data analytics to enhance opioid stewardship programs, addressing challenges health care professionals face, and providing strategies for effective patient care, leveraging data, and fostering supportive environments.

Experts discuss advantages of prefilled syringes in opioid delivery—reducing errors, enhancing safety, and minimizing waste—while providing insights on optimizing dosage forms.

Experts discuss opioid use with a focus on validated assessment tools, monitoring strategies, and risk mitigation practices, delving into the complexities of pain scales and emphasizing the need for functional assessments.

Health care professionals discuss navigating challenges in opioid management, emphasizing a patient-centric approach, and address barriers and differences among opioid misuse, abuse, and use disorder.

Stephanie Abel, PharmD, BCPS, and Megan Mitchell, PharmD, MS, discuss pharmacist roles in combating biases, fostering collaboration with prescribers, and implementing strategies for effective opioid stewardship.

A panel of experts share insights on overcoming challenges in responsible opioid prescribing and explore emotional responses, aversion to change, and the role of interdisciplinary collaboration in addressing the opioid crisis.

As we reflect on the flurry of activity in the health care data privacy and security space in 2023 and look ahead to what will continue to be a busy 2024, we are seeing the early stages of federal agency

On December 13, 2023, the U.S. Department of Health and Human Services' (HHS) Office of the National Coordinator for Health Information Technology (ONC) released the Health Data, Technology, and Interoperability...

Digital health companies, investors, and other health care organizations should follow policy developments with a strategic lens towards their market opportunities...

As we reflect on the flurry of activity in the health care data privacy and security space in 2023 and look ahead to what will continue to be a busy 2024, we are seeing the early stages...